These data provide evidence that lumican evokes EMT/MET reprogramming in ERα knockdown cells, by suppressing the gene and protein levels of major EMT modulators in the mesenchymal, aggressive breast cancer cells. The gene discussed is LUM; the disease is breast carcinoma.